APP and Alzheimer disease: Zhang et al. conducted an animal study using APP/PS1 (amyloid precursor protein/presenilin 1) transgenic AD mice, which revealed lower concentrations of butyric acid in both feces and the brain, along with a decrease in the abundance of Butyricicoccus pullicaecorum, a butyrate-producing bacterium.